Business Wire

IFF expands LMR Naturals site in Grasse, advancing naturals innovation leadership

Share

A €10 million investment enhances capacity, sustainability and innovation in the heart of the world’s perfume capital.

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and biosciences, today inaugurated its expanded LMR Naturals site in Grasse following a €10 million investment. The expansion increases the facility’s footprint by 75 percent to 4,687 square meters and includes a state-of-the-art pilot hall designed to accelerate the development of new natural ingredients. The upgraded site also counts on a newly completed experimental field nearby that will provide direct access to plant materials, enabling deeper exploration of botanical potential and fast-tracking ingredient innovation. The expansion brings together more than 30 research and development experts under one roof, enhancing IFF’s ability to meet rising global demand for traceable, sustainable and high-quality naturals.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908487443/en/

Credit: IFF

“LMR Naturals is a strategic asset in IFF’s portfolio, and this expansion underscores our commitment to shaping the future of natural ingredients,” said Erik Fyrwald, IFF CEO. “By deepening our roots in Grasse — the global center of excellence for natural ingredients — we’re scaling innovation that empowers perfumers and flavorists worldwide to deliver high-performing, exceptional and sustainable signatures consumers trust.”

LMR Naturals is a trademarked capability within IFF, originally founded in 1983 by Monique Remy and acquired by IFF in 2000 to enhance IFF’s ability to provide perfumers with high-quality, innovative and, sustainably sourced and produced natural ingredients at competitive cost. Today, perfumers around the world leverage the deep expertise of LMR scientists to create the signature of unforgettable fragrances for customers and across applications such as fine perfumery, cosmetics, home care, fabric care and beauty care. LMR Naturals also provides ingredients for taste applications.

“LMR’s ability to fuse tradition with cutting-edge innovation is unmatched,” said Sabrya Meflah, president of IFF’s fine fragrance segment. “This expansion is more than bricks and mortar—it’s a launchpad for the next generation of naturals that will shape the future of fine perfumery, with applications across all IFF businesses. Our footprint in Grasse now enables a seamless transition from seed to bottle, with our Atelier du Parfumeur just steps away.”

“With a newly expanded site now fully operational, we intend to launch four to six new products each year, with sustainability at the heart of our approach — reflected in our dual certifications, For Life and Zero Waste to Landfill, and a waste valorization rate of at least 98 percent,” said Bertrand de Preville, general manager of LMR Naturals.

LMR Naturals introduced 23 new ingredients since 2020 and earned notable accolades, including seven awards from CosmetiqueMag and recognition from the Organic Monitor Sustainable Beauty Awards. Meanwhile, the LMR Naturals team remains committed to its founding vision: revealing the purity of natural ingredients while respecting the environment and sourcing partners. LMR currently processes 85,000 tons of biomass annually, produces 2,000 tons of extracts and offers more than 850 ingredients across 130 botanical families.

With this expansion, IFF reaffirms its strategic investment in the Grasse region, which now includes more than 230 employees and positions it as a global hub for natural ingredient innovation and excellence.

Visit LMR Naturals at https://lmrnaturals.iff.com, LinkedIn, and Instagram.

Cautionary Statement under the Private Securities Litigation Reform Act of 1995

This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “plan”, “expect,” “anticipate,” “intend,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the timing or nature of the expansion, its operations or future product launches. There are many risks and uncertainties inherent in our business that could cause actual results and events to differ materially from those in the forward-looking statements. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.

Welcome to IFF

At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Learn more at iff.com, LinkedIn, Instagram and Facebook.

© 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250908487443/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

'RevoAb™', A New Service for Antibody Developability Engineering9.9.2025 10:00:00 CEST | Press release

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform, called aiProtein® is pleased to announce the launch of a new contract research service, 'RevoAb™'. This service engineers antibodies to improve physicochemical properties while protecting antigen binding affinity. About RevoAb™ Since December 2023, RevolKa has offered contract research services for antibody engineering using aiProtein®, its AI-driven protein engineering technology, through FUJIFILM Wako Pure Chemical Corporation in Japan. RevoAb™ is a new online service for antibody developability engineering based on "RevolKa's Refined Naturalness Design concept," This refines antibody framework sequences to be close to those in naturally occurring antibodies. The pilot version was released in Japan in July 2025. Based on customer feedback, we are now launching an upgraded RevoAb™ world-wide. With RevoAb™, users can instantly access multiple antibody seq

Sisvel Appoints IP Leader to Head China Business and Establish Shenzhen Office9.9.2025 09:38:00 CEST | Press release

Sisvel has appointed Yixiong Zou to lead its operations in China. He will be responsible for steering the company’s licensing, programme management and business development efforts in the country, and will manage a new Sisvel office to be established in Shenzhen. Mr Zou joins the company as Managing Director, China and is the first person to hold this title. His appointment reflects the importance that Sisvel attaches to the Chinese market. In a career spanning more than 25 years, Mr Zou has held engineering, legal and licensing roles with major technology companies in both China and the United States. Most recently, he was Associate General Counsel at renewable energy technology company AESC US. Mr Zou attended Shanghai Jiao Tong University before relocating to the US, where he earned a bachelor’s degree in electrical engineering from Florida State University and a master’s degree in electrical engineering from the University of Southern California. After beginning his working life at

Autel Energy Collaborates with Phoenix Contact to Integrate High-Current CCS2 Technology into New Megawatt-Class Charging System9.9.2025 09:30:00 CEST | Press release

As part of its global product launch event “Infinite Power – Starting from Zero,” Autel Energy introduced a high-power charging system from the MaxiCharger DT1000 series, integrating Phoenix Contact’s latest 1,000A liquid-cooled CCS Type 2 cable and connector system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909054584/en/ Autel Energy showcased the MaxiCharger DT1000 terminal integrating Phoenix Contact’s latest liquid-cooled CCS2 cable and connector. This marks the first integration of Phoenix Contact’s 1,000A CCS2 technology into the MaxiCharger DT1000 series—expanding its capability to serve high-power applications such as heavy-duty vehicles, commercial fleets or even high-performance passenger cars, while enhancing thermal stability and system-level compatibility. “By integrating Phoenix Contact’s new CCS2 connector into our MaxiCharger DT1000, we can bring this technology into a complete system — from modular c

Varian Announces CE Mark for Embozene in Genicular Artery Embolisation, Expanding Treatment for Knee Osteoarthritis9.9.2025 09:00:00 CEST | Press release

Varian, a Siemens Healthineers company, announced today that its Embozene microspheres have received CE Marking for Genicular Artery Embolisation (GAE) for knee osteoarthritis. This regulatory milestone makes Embozene the first—and only—embolic agent to be CE Marked specifically for GAE, a minimally invasive procedure intended to target inflammation and help relieve pain in patients with knee osteoarthritis. Knee osteoarthritis is widespread, with a reported prevalence of nearly 375 million cases globally¹ and can significantly impair physical function and quality of life. While current treatments – such as physical therapy, medications, and intra-articular injections – offer temporary relief, many patients are not yet ready for, or wish to delay, total knee replacement surgery. This gap in care highlights the need for new options that can help patients manage pain and maintain function. GAE is designed to help fill that gap. The procedure involves advancing a small catheter into the g

Ant International’s Bettr Lending Empowers SMEs on Global E-Commerce Platforms as Year-End Shopping Sprees Near9.9.2025 08:31:00 CEST | Press release

Bettr, a leading provider of embedded financing and tech solutions under Ant International, today announced the launch of its AI-driven accounts receivable financing solution designed to provide global e-commerce platform vendors with rapid and secure access to working capital as they prepare for the year-end shopping sprees. Bettr’s solution directly addresses a critical pain point for online vendors on global e-commerce platforms: the need for fast, flexible, and reliable funding to manage increased inventory, marketing spends, and operational costs during the busiest retail period of the year. It leverages advanced AI and machine learning to deliver a seamless experience. “Our goal is to give the vendors the financial agility they need to capitalize on a massive opportunity,” said Quan Yu, General Manager of Credit Services, Ant International. “By integrating our alternative data-powered credit assessment and risk management directly into the e-commerce ecosystem, we can quickly app

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye